Product Information
Registration Status: ActiveSIN12259P
RELESTAL PEDIATRIC SYRUP 10mg/5ml is approved to be sold in Singapore with effective from 2003-04-25. It is marketed by FAR EAST DRUG COMPANY PTE LTD, with the registration number of SIN12259P.
This product contains Dicycloverine 10mg/5ml in the form of SYRUP. It is approved for ORAL use.
This product is manufactured by UNITED LABORATORIES INC in PHILIPPINES.
It is a Pharmacy Only Medicine that can be obtained from a pharmacist at a retail pharmacy.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms. [PubChem]
Indication
For the treatment of functional bowel/irritable bowel syndrome including Colicky abdominal pain; diverticulitis
Mechanism of Action
Action is achieved via a dual mechanism: (1) a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and (2) a direct effect upon smooth muscle (musculotropic).
Active Ingredient/Synonyms
2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate | Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester | Dicicloverina | DICYCLOMINE | Dicycloverin | Dicycloverine | Dicycloverinum | Dicyclomine |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.